These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29330011)

  • 1. Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatment.
    Ruiz-García R; Vargas-Hernández A; Chinn IK; Angelo LS; Cao TN; Coban-Akdemir Z; Jhangiani SN; Meng Q; Forbes LR; Muzny DM; Allende LM; Ehlayel MS; Gibbs RA; Lupski JR; Uzel G; Orange JS; Mace EM
    J Allergy Clin Immunol; 2018 Aug; 142(2):605-617.e7. PubMed ID: 29330011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.
    Lucas CL; Kuehn HS; Zhao F; Niemela JE; Deenick EK; Palendira U; Avery DT; Moens L; Cannons JL; Biancalana M; Stoddard J; Ouyang W; Frucht DM; Rao VK; Atkinson TP; Agharahimi A; Hussey AA; Folio LR; Olivier KN; Fleisher TA; Pittaluga S; Holland SM; Cohen JI; Oliveira JB; Tangye SG; Schwartzberg PL; Lenardo MJ; Uzel G
    Nat Immunol; 2014 Jan; 15(1):88-97. PubMed ID: 24165795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome.
    Cohen JI
    Front Immunol; 2018; 9():237. PubMed ID: 29599765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8
    Cannons JL; Preite S; Kapnick SM; Uzel G; Schwartzberg PL
    Front Immunol; 2018; 9():1758. PubMed ID: 30116245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of a Chinese Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome.
    Wang Y; Wang W; Liu L; Hou J; Ying W; Hui X; Zhou Q; Liu D; Yao H; Sun J; Wang X
    J Clin Immunol; 2018 Nov; 38(8):854-863. PubMed ID: 30499059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity.
    Edwards ESJ; Bier J; Cole TS; Wong M; Hsu P; Berglund LJ; Boztug K; Lau A; Gostick E; Price DA; O'Sullivan M; Meyts I; Choo S; Gray P; Holland SM; Deenick EK; Uzel G; Tangye SG
    J Allergy Clin Immunol; 2019 Jan; 143(1):276-291.e6. PubMed ID: 29800648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and genetic analysis for activated PI3K-δ syndrome by PIK3CD gene mutation].
    Liu H; Tang XL; Liu JR; Li HM; Zhao SY
    Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):698-702. PubMed ID: 27596086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells.
    Saghafian-Hedengren S; Sohlberg E; Theorell J; Carvalho-Queiroz C; Nagy N; Persson JO; Nilsson C; Bryceson YT; Sverremark-Ekström E
    J Virol; 2013 Dec; 87(24):13446-55. PubMed ID: 24089567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide-3-Kinase Signaling in Human Natural Killer Cells: New Insights from Primary Immunodeficiency.
    Mace EM
    Front Immunol; 2018; 9():445. PubMed ID: 29563913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
    Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
    Front Immunol; 2020; 11():1231. PubMed ID: 32625211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early diagnosis of PI3Kδ syndrome in a 2 years old girl with recurrent otitis and enlarged spleen.
    Saettini F; Pelagatti MA; Sala D; Moratto D; Giliani S; Badolato R; Biondi A
    Immunol Lett; 2017 Oct; 190():279-281. PubMed ID: 28842185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and immunological analysis of patients with activated phosphoinositide 3-kinase δ syndrome resulting from PIK3CD mutation].
    Tang WJ; Wang W; Luo Y; Wang YP; Li L; An YF; Gou LJ; Ma MS; He TY; Yang J; Zhao XD; Song HM
    Zhonghua Er Ke Za Zhi; 2017 Jan; 55(1):19-24. PubMed ID: 28072954
    [No Abstract]   [Full Text] [Related]  

  • 13. Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype.
    Zhao P; Huang J; Fu H; Xu J; Li T; Zhang X; Meng Q; Zhang L; Tan L; Zhang W; Chen H; Lu X; Ding Y; He X
    Pediatr Rheumatol Online J; 2024 Jan; 22(1):24. PubMed ID: 38287413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
    Vargas-Hernández A; Mace EM; Zimmerman O; Zerbe CS; Freeman AF; Rosenzweig S; Leiding JW; Torgerson T; Altman MC; Schussler E; Cunningham-Rundles C; Chinn IK; Carisey AF; Hanson IC; Rider NL; Holland SM; Orange JS; Forbes LR
    J Allergy Clin Immunol; 2018 Jun; 141(6):2142-2155.e5. PubMed ID: 29111217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaustion of the CD8
    Wentink MWJ; Mueller YM; Dalm VASH; Driessen GJ; van Hagen PM; van Montfrans JM; van der Burg M; Katsikis PD
    Front Immunol; 2018; 9():446. PubMed ID: 29563914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Frequency of CMV Replication and Disease Complications Reveals New Cellular Defects and a Time Dependent Pattern in CVID Patients.
    Marri L; Contini P; Ivaldi F; Schiavi C; Magnani O; Vassallo C; Guastalla A; Traversone N; Angelini C; Del Zotto G; De Maria A; De Palma R
    J Clin Immunol; 2024 Jun; 44(6):142. PubMed ID: 38847943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel de novo gain-of-function mutation of PIK3CD in a patient with activated phosphoinositide 3-kinase δ syndrome.
    Luo Y; Xia Y; Wang W; Li Z; Jin Y; Gong Y; He T; Li Q; Li C; Yang J
    Clin Immunol; 2018 Dec; 197():60-67. PubMed ID: 30138677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Mutation in the Moesin (MSN) Gene Leads to Immunodeficiency with Epstein-Barr Virus (EBV) Infection and Dermatomyositis-Like Symptoms.
    Sun B; Liu L; Han L; Li Q; Wu Q; Hou J; Wang W; Ying W; Zhou Q; Qian F; Lu W; Wang X; Sun J
    J Clin Immunol; 2024 Jun; 44(7):155. PubMed ID: 38922539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function.
    Welsh RM; Brubaker JO; Vargas-Cortes M; O'Donnell CL
    J Exp Med; 1991 May; 173(5):1053-63. PubMed ID: 1850779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome.
    Condliffe AM; Chandra A
    Front Immunol; 2018; 9():338. PubMed ID: 29556229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.